Skip Navigation
Skip to contents

ACC : Acute and Critical Care

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Acute Crit Care > Volume 41(3); 2026 > Article
Original Article
Pediatrics
Pediatric post-intensive care malnutrition—risk factors and their association with long-term functional outcomes 1 year after discharge: a retrospective cohort study in Thailand
Acute and Critical Care 2026;41(3):641-653.
DOI: https://doi.org/10.4266/acc.005650
Published online: August 31, 2026

1Division of Pediatric Nutrition, Department of Pediatrics, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathumthani, Thailand

2Division of Pediatric Critical Care, Department of Pediatrics, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathumthani, Thailand

Corresponding author: Chanapai Chaiyakulsil Division of Pediatric Critical Care, Department of Pediatrics, Thammasat University Hospital, Faculty of Medicine, Thammasat University, 95 Phahol Yothin Rd, Klong-Neung, Klong-Luang, Pathumthani 12120, Thailand Tel: +66-29-26-9514 Email: chanapai.chai@hotmail.com
• Received: September 30, 2025   • Revised: July 15, 2026   • Accepted: July 21, 2026

© 2026 The Korean Society of Critical Care Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 1,138 Views
  • 28 Download
  • 1 Web of Science
  • 1 Crossref
  • 1 Scopus
prev next
  • Background
    Data on the long-term nutritional status of pediatric intensive care unit (PICU) survivors are limited, and the association with functional outcomes is unknown. The primary objectives were to determine the prevalence of post-intensive care malnutrition and its relationship with functional outcomes at 1 month and 1 year after PICU discharge.
  • Methods
    A retrospective chart review of all children aged 1 month to 15 years who were admitted to the PICU for >48 hours from July 2019 to January 2024 and had visits to the pediatric post-intensive care clinic at 1 month and 1 year after hospital discharge was conducted. Malnutrition was categorized using the body mass index according to the World Health Organization Growth Reference. Functional outcome was classified using the Pediatric Cerebral Performance Category.
  • Results
    A total of 129 children were included in the final analysis. Malnutrition was observed in 46 children (35.6%) at 1 month after discharge and in 29 children (22.5%) at 1 year after discharge. Children with baseline malnutrition were associated with malnutrition at both follow-up time points. Longer ventilator days were observed among children with malnutrition at both time points, and children who had malnutrition at 1 year had longer PICU stays. At least moderate dysfunction was associated with any malnutrition and wasting at 1 year after discharge, but not with overweight.
  • Conclusions
    Malnutrition was found in a substantial proportion of PICU survivors, with an association with poor long-term Pediatric Cerebral Performance Category-related functional outcomes. Long-term nutritional follow-up and support should be warranted to optimize outcomes.
Malnutrition in critically ill children is a common phenomenon with a major impact on acute outcomes, with increasing infection rates and mortality [1,2]. The prevalence of undernutrition on intensive care admission ranges from 8.1% to 71.7%, with faltering growth found in 13.7% of critically ill children with normal body mass index (BMI) [3-6]. Most studies in the literature focused on short-term outcomes, including in-hospital mortality, length of pediatric intensive care unit (PICU) stay, and hospital length of stay [1-3,5,6]. It is well known that malnutrition in children, especially during infancy, is associated with poor growth and delayed psychomotor and mental development [7]. However, little is known concerning the long-term nutritional status and its association with functional outcomes of critically ill children who survived intensive care. A study by Ventura et al. [8] in 2020 found that undernutrition, as defined by BMI-for-age, mid-upper arm circumference-for-age, and triceps skin fold thickness-for-age, was associated with a higher 60-day mortality rate. It has been shown in the adult population that negative protein balance during critical illness can affect long-term muscle function and quality of life [9]. In children, two long-term studies showed recovery of nutritional status at 3 and 6 months after discharge, with no data on functional outcomes [10,11].
In the current literature, data on the long-term nutritional status of PICU survivors are limited, and its association with long-term function is unknown. Furthermore, in the study by Hulst et al. [10] in 2004, the majority of children (200/293, 68.2%) in the cohort were neonates, which further limited data on PICU survivors and warranted further studies. Thus, the main objectives of this study were to determine the prevalence of post-intensive care malnutrition among PICU survivors and to assess the association between nutritional status and functional outcomes at 1 month and 1 year after PICU discharge. Risk factors for malnutrition were also identified.
This study was approved by the Ethics Committee of Thammasat University Hospital, Thammasat University, Thailand (No. MTU-PE-TU-0-060/68). Due to the retrospective nature of the study, informed consent was waived.
Study Design and Participants
A retrospective chart review of all children aged 1 month to 15 years who were admitted to the PICU of the study institution for >48 hours from July 2019 to January 2024 and had a visit to the pediatric post-intensive care clinic at 1 month and 1 year after hospital discharge was conducted. The PICU at our center is a seven-bed mixed medical-surgical tertiary intensive care unit with approximately 25–30 patient admissions per month.
Pediatric Post-intensive Care Clinic
The clinic is held once a week by a consultant pediatric intensivist who is responsible for the evaluation, screening, and initial management of morbidity associated with post-intensive care syndrome. All patients who stayed in the PICU for >48 hours were scheduled for a follow-up visit at 2–4 weeks after hospital discharge. During the visit, general health and functional outcomes were evaluated using the Pediatric Cerebral Performance Category (PCPC). Anthropometric measurements, medication reconciliation, developmental progression evaluation, vaccination, and school performance assessment were also conducted during the visit. Furthermore, parental concerns and questions were also addressed. The multidisciplinary team and consultants, such as developmental-behavioral pediatricians, pediatric physiotherapists and occupational therapists, pediatric dentists, pediatric nutritionists, and speech therapists, were also involved in the care of these children as indicated. Regular follow-ups were designed based on the problem of each individual. Children with at least two visits showing normal development for their age, without school or parental concerns, for at least 1 year after hospital discharge were discharged from the clinic.
Operational Definitions
Malnutrition in this study was defined as a nutritional status outside the normal range for age, whether resulting in wasting or overweight. Nutritional statuses were classified into four groups: wasting, normal, overweight, and obese. For children <5 years of age, overweight and obesity are defined as weight-for-height >2 and >3 standard deviations (SDs) above the World Health Organization (WHO) Child Growth Standard median, respectively. Overweight and obesity in children and adolescents aged 5–15 years are defined as BMI-for-age >1 or >2 SD above the WHO Growth Reference median, respectively. Wasting is defined as weight-for-height or BMI-for-age <–2 SD [12-14].
Post-intensive care functional outcomes in this study are defined using the PCPC. PCPC was developed in 1992 to effectively measure and quantify the morbidity of children after critical illness. It primarily focuses on daily life and cognitive morbidity. The PCPC scale ranges from 1 (normal) to 6 (brain death): 2 (mild disability), 3 (moderate disability), 4 (severe disability), 5 (coma or vegetative state) [15,16]. All demographic data, baseline nutritional status, admission diagnosis, underlying comorbidities, PICU duration, ventilator days, anthropometric measurements, and PCPC at 1 month and 1 year after hospital discharge were documented. A participant admitted more than once was documented only once based on the first PICU admission.
Statistical Analyses
Children with nutritional status outside of the normal range for age, whether it was wasting or overweight, were classified as having malnutrition. Overweight and obesity were collectively referred to as overweight in the final analyses. PCPC scores from 2 to 6 were defined as abnormal functional outcomes. All demographic data, anthropometric measurements, PICU length of stay, and ventilator days were analyzed using descriptive statistics (mean, SD, median, and range where appropriate). The prevalence of post-intensive care malnutrition and abnormal functional outcomes was reported in percentages. Risk factors were analyzed using the chi-square test or Fisher’s exact test, where appropriate. Univariate and multivariate analyses were also performed. To avoid overfitting and account for all possible confounders, the multivariate analysis model used enter selection and statistical criteria rather than specific clinical criteria to adjust for them. Only factors with P<0.05 from the univariate analyses were included in the multivariate analyses. A complete-case analysis approach was used, and all cases with missing data were excluded from the final analyses. All statistical analyses were performed using IBM SPSS version 24 (IBM Corp.).
Demographic Data
A total of 177 children met the inclusion criteria. Incomplete anthropometric measurements were found in 15 children, 32 children were lost to follow-up, and one child died before the 1-year follow-up, resulting in a total of 129 children in the final analyses (Figure 1). The demographic data of the children are shown in Table 1. Male participants constituted the majority of the population (66.7%), with the median age of 2.0 years (interquartile range [IQR], 0.4–5.0). Approximately 68.3% of the children had underlying comorbidities, with the majority being cardiovascular conditions (49.5%). Cardiovascular conditions and pulmonary conditions were the most common diagnoses for PICU admissions, accounting for 55.0% and 19.3%, respectively. Baseline malnutrition was found in 52 children (40.3%). Wasting was documented in 30 children (23.3%) at baseline, while another 22 children (17.1%) were overweight or obese.
Eighty-two children (63.6%) received inotropic support during PICU admission, with the median vasoactive inotropic score (VIS) [18] of 14.0 (IQR, 5.8–34.8). The median Pediatric Risk of Mortality III (PRISM III) [17] was 3.0 (IQR, 0.0–6.5). Mechanical ventilation was required in 110 children (85.3%), and 48 children (37.2%) were mechanically ventilated for more than 7 days. Continuous infusion of sedation and neuromuscular blockers was used in 103 children (79.8%) and 29 children (22.5%), respectively. Fifteen children (11.6%) required extracorporeal membrane oxygenation (ECMO) support. The median ventilator support time and median PICU stay were 6.0 days (IQR, 2.0–14.0) and 9.0 days (IQR, 5.0–17.0), respectively.
Overall Nutritional Status after Discharge
Table 1 presents the overall nutritional status during the study population's follow-up. Forty-eight children (37.2%) had malnutrition at any follow-up time point. Wasting was documented in 31 children (24.0%), and 17 children (13.2%) were either overweight or obese. The median age at PICU admission did not differ significantly between children with normal nutritional status and those with malnutrition (1.6 years [IQR, 0.4–4.0] vs. 2.1 years [IQR, 0.4–6.5]; P=0.368). The median weight and height on admission were also not significantly different among groups. Children with baseline malnutrition were more likely to have malnutrition during the follow-up period (75.0% vs. 19.8%, P<0.001), with a crude odds ratio (OR) of 12.19 (95% CI, 5.20–28.57; P<0.001).
The median time for the initiation of enteral feeding during the PICU admission (2.0 days [IQR, 1.0–3.0] in children with normal nutritional status vs. 2.5 days [IQR, 1.0–3.0] for children with malnutrition; P=0.195) and the median time to reach the goal of full enteral feeding per physician (4.0 days [IQR, 3.0–7.0] in children with normal nutritional status vs. 5.0 days [IQR, 4.0–7.8] for children with malnutrition; P=0.309) were not significantly different among groups. Total parenteral nutrition utilization was not significantly different among groups (9.9% in children with normal nutrition vs. 8.3% in children with malnutrition; P=1.000). Children with malnutrition were more likely to receive medical formula at home after discharge (37.5% vs. 17.3%; P=0.010) with the crude OR of 2.87 (95% CI, 1.26–6.52; P=0.010). A significantly higher proportion of children who were mechanically ventilated for more than 7 days was found in the malnutrition group (47.9% vs. 30.9%; P=0.027). The proportions of children receiving inotropic support, ECMO support, continuous infusion of sedation and neuromuscular blockers, mechanical ventilation, and prolonged PICU stay of more than 7 days were similar among the groups, as were the median PRISM III and VIS. A significantly higher proportion of children with abnormal PCPC was documented in the malnutrition group at both 1 month (68.7% vs. 59.3%; P=0.016) and 1 year of follow-up (52.1% vs. 39.5%; P=0.016). Moreover, children with malnutrition were associated with at least moderate dysfunction at any time during the follow-up, with a crude OR of 4.06 (95% CI, 1.85–8.92; P<0.001). Using the multivariate analyses, only children with baseline malnutrition and children with at least moderate dysfunction at any time point were associated with malnutrition, with adjusted odds ratios (aOR) of 16.52 (95% CI, 5.63–48.41; P<0.001) and 3.46 (95% CI, 1.05–11.34; P=0.041), respectively. Table 2 illustrates the univariate and multivariate analyses of factors associated with malnutrition after discharge at any time point.
In the subgroup of children with wasting at any time point after discharge, the data were shown in Supplementary Tables 1 and 2. Children with wasting at baseline were more likely to have wasting at any time point during the follow-up (11.2% in children without baseline wasting vs. 67.7% in children with baseline wasting; P<0.001), with a crude OR of 16.60 (95% CI, 6.23–44.25; P<0.001). The proportions of children receiving medical formula and tube feeding at home after discharge were significantly higher among children with wasting. Furthermore, children with wasting were more likely to receive inotropic support, ECMO support, and be mechanically ventilated for more than 7 days during their PICU admission. There were also higher proportions of children with at least moderate dysfunction from PCPC in children with wasting after PICU discharge (58.1% vs. 22.4%, P<0.001). After multivariate analyses, baseline wasting, using a medical formula at home, receiving inotropic support during PICU admission, and at least moderate dysfunction were significantly associated with wasting at follow-up.
Supplementary Tables 3 and 4 present data for the subgroup of children with overweight at any time point after discharge. The median weight and height on PICU admission were greater among children with overweight. Children younger than 1 year old, children with cardiac diagnoses, and children receiving inotropic support during PICU admission were less likely to be overweight during the follow-up. On the other hand, children with baseline overweight were more likely to be overweight at follow-up, with a crude OR of 48.75 (95% CI, 12.55–189.35; P<0.001). After adjustment for confounders, only children with baseline overweight were more likely to be overweight during follow-up, with an aOR of 34.01 (95% CI, 7.38–156.63; P<0.001).
Nutritional Status at 1 Month after Discharge
Malnutrition was documented in 46 children (35.6%) at 1 month after discharge, with wasting in 29 children (22.5%) and overweight in 17 children (13.2%). Similarly, children with baseline malnutrition were more likely to have malnutrition at 1 month (80.4% vs. 18.1%; P<0.001), with the crude OR of 18.64 (95% CI, 7.44–46.68; P<0.001) (Tables 3 and 4). There was also a higher proportion of children who received medical formula at home in the malnutrition group (37.0% vs. 18.1%; P=0.017), with a crude OR of 2.66 (95% CI, 1.17–6.03; P=0.017). Children who were mechanically ventilated for more than 7 days and children who had at least moderate dysfunction at 1 month using PCPC were again noted to be associated with malnutrition at 1 month after discharge. Children with malnutrition had a longer median number of ventilator days during their PICU admission compared with those without malnutrition (9.5 days [IQR, 4.0–19.0] vs. 5.0 days [IQR, 2.0–10.8], P=0.018). Using multivariate analyses, only baseline malnutrition was associated with malnutrition at 1 month after discharge, with an aOR of 31.42 (95% CI, 9.35–105.62; P<0.001) (Table 4).
Supplementary Tables 5 and 6 summarize data on wasting at 1 month and at 1 year after discharge, and present univariate and multivariate analyses of the association. Among children with wasting at 1 month after discharge, the median weight at 1 month was lower than in children without wasting (weight: 12.6kg [IQR, 8.4–23.3] in children without wasting vs. 6.8 kg [IQR, 4.8–13.0]; P=0.017). There was also a significantly higher proportion of infants younger than 1 year of age in the wasting group (55.2% vs. 33.0%; P=0.030). Similar to the previous findings of wasting at any time point, children with baseline wasting, children who received medical formula and tube feeding at home, children receiving inotropic support, mechanical ventilation for greater than 7 days, and children with at least moderate disability at 1 month were associated with the development of wasting at 1 month. After adjustment for confounders, only baseline wasting was associated with wasting at 1 month after discharge, with the aOR of 143.41 (95% CI, 15.32–1342.76; P<0.001).
Children who were overweight at 1 month were older than those with normal nutritional status (median age, 5.6 years [IQR, 3.3–11.8] vs. 1.4 years [IQR, 0.3–4.1]; P=0.005). The median weight and height at 1 month were also greater in the overweight group than in children who were not overweight. It was again noted that children younger than 1 year old, children with cardiac diagnoses, and children receiving inotropic support were less likely to be overweight at 1 month. In contrast, children who were overweight at baseline were more likely to be overweight at 1 month. After multivariate analyses, the only associated factor with being overweight at 1 month was being overweight at baseline, with an aOR of 179.37 (95% CI, 27.13–1,185.85; P<0.001) (Supplementary Tables 7 and 8).
Nutritional Status at 1 Year after Discharge
At 1 year, 29 children (22.5%) were found to have malnutrition. Wasting was documented in 15 children (11.7%), and 14 children (10.8%) were overweight. Children who had baseline malnutrition were more likely to have malnutrition at 1 year (75.9% vs. 30.0%; P<0.001), with a crude OR of 7.33 (95% CI, 2.83–19.00; P<0.001) (Tables 3 and 4). Children with baseline developmental delays, children who were mechanically ventilated and received continuous infusion for more than 7 days, and children who had at least moderate dysfunction at 1 year were noted to be associated with malnutrition at 1 year. The median ventilator days and median PICU stays were also longer in the malnutrition group. Using multivariate analyses, baseline malnutrition and moderate dysfunction at 1 year were significantly associated with malnutrition at 1 year after discharge.
It was demonstrated that children with baseline wasting, baseline global developmental delay, children receiving medical formula and tube feeding at home, children receiving ECMO support and mechanical ventilation and sedation for longer than 7 days, and children with at least moderate disability at 1 year were associated with wasting at 1 year using univariate analyses. After confounder adjustment, baseline wasting, children receiving ECMO support, and children with moderate dysfunction at 1 year were associated with wasting 1 year later. These data were summarized in Supplementary Tables 5 and 6.
The median weight and height among children who were overweight at 1 year were greater when compared to children who were not overweight (Supplementary Table 7). Children with cardiac diagnoses and children who received inotropic support during their PICU admission were again less likely to be overweight, with a positive association shown in children who were overweight at baseline. Similar to being overweight at any time point and overweight at 1 month, only a positive association was found in children who were overweight at baseline, with the aOR of 37.25 (95% CI, 8.56–162.12; P<0.001) (Supplementary Table 8).
The current study revealed a substantial proportion of children with malnutrition after PICU discharge, with 22.5% of children still having malnutrition after 1 year of discharge. Despite a decline from a steep 40.3% of baseline malnutrition, this proportion was still alarming. A study by Ventura et al. [8] demonstrated that baseline undernutrition was associated with a higher risk of 60-day mortality and a longer PICU stay. Still, it did not assess the prevalence of long-term nutritional status and its association with intensive care interventions and functional outcomes in PICU survivors [8]. Based on the current data, the long-term nutritional status of the survivors was associated with PICU interventions. Children who received inotropic support were more likely to develop wasting at any time point of follow-up, and ECMO support was associated with the development of wasting at 1 year of follow-up. Furthermore, longer ventilator days were observed in children who developed any malnutrition at 1 month and 1 year post-discharge, and longer PICU stays were observed in children developing any malnutrition at 1 year post-discharge. These implications should be noted among the children with higher severity and those with prolonged PICU stays.
Moreover, it was found that wasting at any time point after discharge, any malnutrition at 1 year, and wasting at 1 year were associated with at least moderate dysfunction in functional outcomes, as measured by PCPC. This coincided with a study of an adult population that found that inadequate nutritional intake was associated with the severity of prolonged physical impairments [19]. In critically ill patients, a series of dysregulated metabolic and inflammatory responses during intensive care can lead to an ineffectiveness of nutrient utilization for the maintenance of muscle mass, leading to muscle loss, and ultimately post-intensive care weakness [20]. Furthermore, malnutrition during ICU stay and inadequate nutritional intake after intensive care discharge would further contribute to the physical dysfunction of the critical care survivors [21]. An adult study by Salisbury et al. [22] demonstrated that decreased nutritional intake persists even after 1 year post-discharge, with survivors receiving only 70% of optimal intake. Approximately 13.3% of adult critical care survivors in a study by Rousseau et al. [19] had protein intake below the required level for post-intensive care patients at 1 year after critical illness. The decrease in nutritional intake could be from prolonged loss of appetite due to taste disorders, prolonged depression, post-intensive care dysphagia, and post-intensive care anxiety [21,23,24]. This can further contribute to prolonged undernutrition and poor long-term functional outcomes, and can negatively impact the quality of life of PICU survivors.
Wasting was noted in 22.5% at 1 month and 11.7% at 1 year after discharge in the current cohort. These findings were inconsistent with the study by Hulst et al. [10], which suggested that almost all children had a complete recovery from nutritional undernourishment after 6 months of follow-up. This discrepancy might be due to the different population groups, with the majority being the neonatal population, and different follow-up times, along with the lower proportion of children with malnutrition at baseline (24.0%) [10]. However, the findings from the current study were comparable to those from the adult study, which included patients hospitalized for coronavirus disease 2019 (COVID-19) infection, in which 28.6% of survivors were malnourished at 30 days after hospital discharge, with the effect more pronounced in patients requiring intensive care [25]. Approximately 58.6% and 53.3% of children with wasting at 1 month and 1 year had moderate dysfunction at 1 month and 1 year, respectively. These associations of long-term dysfunction and wasting after critical illness further highlight the importance of nutritional follow-up and intervention beyond the critically ill period. As baseline wasting was also associated with wasting at both follow-up time points, patients with baseline wasting should be closely monitored. A Global Leadership Initiative on Malnutrition in 2025 suggested that in critically ill adults, nutritional status should be reevaluated before intensive care discharge and during clinical visits after hospital discharge [20]. Nevertheless, no current recommendation was made in the pediatric population. This study provides novel evidence that long-term nutritional follow-up with functional outcomes should also be warranted in the pediatric population.
Aside from wasting, the association of long-term functional outcomes in overweight and obese children was also a topic of interest. The association between obesity and functional outcomes in the pediatric population has often been debated and has been limited to short-term outcomes at hospital discharge. A study by Ong et al. [26] demonstrated that high BMI was associated with acquired functional impairment at hospital discharge among PICU survivors who stayed in the PICU for more than 2 days, with an aOR of 29.1 (95% CI, 1.39–610.9; P=0.030). Children with greater skeletal mass and higher visceral adipose tissue indices were also associated with poorer functional outcomes at hospital discharge, but the relationship was not significant among children with a PICU stay greater than 2 days, which limited the analysis to those with lower illness severity [26]. In contrast, another study in pediatric trauma showed that after adjustment for confounders, weight was not associated with an abnormal functional outcome at discharge [27]. Unlike children with wasting, there was no significant association between moderate dysfunction and overweight and obesity within the current cohort at both timepoints of follow-up. In the adult population, the phenomenon referred to as the obesity paradox, where patients with obesity had paradoxically better outcomes, was observed among the critical illness survivors. The cohort study of 7,619 adult survivors from critical illness demonstrated that higher BMI was associated with a lower hazard ratio for 4-year mortality [28]. Several proposed mechanisms of this phenomenon include higher energy reserves, greater muscle reserve, and the immunomodulating effect of the adipose tissue [29]. These factors might limit the development of post-intensive care physical dysfunction, hence improving long-term functional outcomes. Nevertheless, the concept of the obesity paradox was still often challenged by contradictory data in the current literature. Some studies suggest that adipokines secreted from adipose tissue, such as tumor necrosis factor-α and interleukin-6, can interfere with skeletal muscle structure and lead to muscle loss [30,31]. However, in both mouse and human models of critical illness, greater myofiber size and muscle strength were observed in overweight subjects compared with lean subjects, possibly due to more effective hepatic fatty acid and glycerol metabolism, as well as ketogenesis, in obese patients [32]. Our lack of association between poor functional outcomes in children who were overweight might be caused by these effects.
As noted earlier, data on long-term nutritional status and its association with long-term functional outcomes are limited in pediatric critical illness survivors. The current study provided insight into the longitudinal evolution of the nutritional status of pediatric critical care survivors after being discharged. Both types of malnutrition, wasting and overweight, along with the trajectory of their functional outcomes, were also addressed, serving as a major strength of this study. These data can help outline the framework of the post-intensive care follow-up in children.
This study has several limitations. The data were primarily based on anthropometric measurements of the children and their BMI. In the general clinical practice in intensive care settings, mid-upper arm circumference, triceps skin fold thickness, and laboratory investigations such as prealbumin were not routinely measured. Due to the retrospective nature of the study, these data were lacking, as were anthropometric measurements. Furthermore, BMI alone is not an appropriate measurement of adipose tissue, fat, and skeletal muscle mass. As this study was single-centered in tertiary care settings, the generalizability of the data was also limited. Due to the limited sample size, a priori clinically important confounders such as severity scores, diagnosis category, or specific comorbidities were not initially included in the multivariable analysis model, regardless of univariable analysis results. A priori statistical criteria of P<0.05 were used instead to prevent overfitting of the multivariable analysis model and to account for all possible confounders. Nevertheless, due to the limited sample size and the retrospective design, the impact of residual confounders cannot be ruled out. Wide confidence intervals across several multivariate models suggest limited precision in the associated results due to the study's relatively small sample size. Furthermore, due to the broad age range in the study and the limited number of populations available for subgroup analyses by age, the observed associations may differ across developmental ages. Moreover, due to the retrospective nature of the study and the highly variable nutritional support protocols among individuals, it is difficult to conduct statistical analyses across protocols. Thus, factors such as median time to initiation of enteral feeding, time to full enteral feeding, use of TPN, receiving medical formula at home, and tube feeding at home were used to broadly categorize nutritional support among individuals. Moreover, a substantial number of the population were excluded in the final analyses due to lacking anthropometric measurements and loss to follow-up; potential selection bias may have occurred.
Another important factor to consider is that, although PCPC is a well-established tool for evaluating global neurological outcomes, it may not reflect the overall functional outcomes of PICU survivors. Furthermore, as the nutritional status and PCPC were evaluated during the same clinical visits at 1 month and 1 year after discharge, a temporal relationship between these variables cannot be fully established. It remains unclear whether malnutrition contributes to poorer functional outcomes, or whether poorer functional outcomes contribute to further malnutrition. Thus, prudence is warranted in interpreting the results, as the association does not imply causality. Although this study provides novel evidence on this interesting subject, larger prospective, multicenter studies are warranted.
In conclusion, malnutrition was found in a substantial proportion of children surviving intensive care. Given its possible association with poor PCPC-related functional outcomes among children, especially those with wasting, long-term nutritional follow-up and support are warranted and should be implemented to optimize their outcomes.
▪ Malnutrition was observed in a considerable proportion of children surviving intensive care, especially those with baseline malnutrition.
▪ Poor functional outcomes, as measured by at least moderate dysfunction by Pediatric Cerebral Performance Category, were associated with children who had any malnutrition and wasting at any time point and 1 year after discharge.
▪ Long-term nutritional follow-up and support are warranted for implementation as a part of post-intensive care follow-up, especially for those with baseline malnutrition, to optimize both nutritional outcomes and functional outcomes in these children.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING

This study was supported by the Research Group in Pediatric Care of the Faculty of Medicine, Thammasat University.

ACKNOWLEDGMENTS

None.

AUTHOR CONTRIBUTIONS

Conceptualization: CC. Data curation: CC, KW. Formal analysis: CC, KW. Funding acquisition: CC. Methodology: CC, KW. Project administration: CC. Visualization: CC, KW. Writing–original draft: CC, KW. Writing–review & editing: CC, KW. All authors read and agreed to the published version of the manuscript.

Supplementary materials can be found via https://doi.org/10.4266/acc.005650.
Supplementary Table 1.
Risk factors for the development of wasting at any time point after discharge
acc-005650-Supplementary-Table-1.pdf
Supplementary Table 2.
Univariate and multivariate analyses for any wasting at any time point after discharge
acc-005650-Supplementary-Table-2.pdf
Supplementary Table 3.
Risk factors for the development of overweight and obesity at any time point after discharge
acc-005650-Supplementary-Table-3.pdf
Supplementary Table 4.
Univariate and multivariate analyses for any overweight and obesity at any time point after discharge
acc-005650-Supplementary-Table-4.pdf
Supplementary Table 5.
Risk factors for the development of wasting at 1 month and 1 year after discharge
acc-005650-Supplementary-Table-5.pdf
Supplementary Table 6.
Univariate and multivariate analyses for wasting at 1 month and 1 year after discharge
acc-005650-Supplementary-Table-6.pdf
Supplementary Table 7.
Risk factors for the development of overweight and obesity at 1 month and 1 year after discharge
acc-005650-Supplementary-Table-7.pdf
Supplementary Table 8.
Univariate and multivariate analyses for overweight and obesity at 1 month and 1 year after discharge
acc-005650-Supplementary-Table-8.pdf
Figure 1.
Population flowchart. PICU: pediatric intensive care unit. a)Lack either weight or height at any time point.
acc-005650f1.jpg
Table 1.
Demographic data based on nutritional status after discharge
Factor All patients (n=129) Normal nutrition (n=81) Malnutrition (n=48) P-value
Age (yr) 2.0 (0–5) 1.6 (0–4) 2.1 (0–7) 0.368
Age <1 yr 49 (38.0) 31 (38.3) 18 (37.5) 0.930
Male sex 86 (66.7) 55 (67.9) 31 (64.6) 0.699
Weight on admission (kg) 11.0 (5.4–18.9) 10.7 (6.2–17.3) 11.7 (4.7–24.4) 0.450
Height on admission (cm) 85.0 (63.5–108.5) 84.5 (65.0–101.0) 90.0 (61.0–115.0) 0.324
Underlying disease 0.652
 None 41 (31.7) 29 (35.9) 12 (25.0)
 Cardiovascular 64 (49.5) 38 (46.9) 26 (54.1)
 Genetic 5 (3.9) 2 (2.5) 3 (6.2)
 Pulmonology 5 (3.9) 3 (3.7) 2 (4.2)
 Neurology 4 (3.1) 2 (2.5) 2 (4.2)
 Allergy 3 (2.3) 3 (3.7) -
 Gastrointestinal 2 (1.6) 1 (1.2) 1 (2.1)
 Developmental disorder 2 (1.6) 1 (1.2) 1 (2.1)
 Hematology and oncology 1 (0.8) 1 (1.2) -
 Rheumatology 1 (0.8) - 1 (2.1)
 Nephrology 1 (0.8) 1 (1.2) -
Admission diagnosis 0.145
 Cardiovascular 71 (55.0) 48 (59.3) 23 (47.9)
 Pulmonology 25 (19.3) 13 (16.1) 12 (25.0)
 Neurology 13 (10.1) 9 (11.1) 4 (8.3)
 Gastrointestinal 6 (4.6) 5 (6.2) 1 (2.1)
 Hematology and oncology 4 (3.1) 1 (1.2) 3 (6.2)
 Nephrology 3 (2.3) 3 (3.7) -
 Dermatology 2 (1.6) 1 (1.2) 1 (2.1)
 Septic shock 2 (1.6) - 2 (4.2)
 Trauma 1 (0.8) - 1 (2.1)
 Genetic 1 (0.8) 1 (1.2) -
 Allergy 1 (0.8) - 1 (2.1)
Baseline malnutrition 52 (40.3) 16 (19.8) 36 (75.0) <0.001
Baseline global developmental delay 17 (13.2) 7 (8.6) 10 (20.8) 0.061
Median time for enteral feeding initiation (day) 2.0 (1.0–3.0) 2.0 (1.0–3.0) 2.5 (1.0–3.0) 0.195
Time to full enteral feeding (day) 5.0 (3.0–7.0) 4.0 (3.0–7.0) 5.0 (4.0–7.8) 0.309
Full enteral feeding after 7 day 28 (21.7) 16 (19.8) 12 (25.0) 0.485
Receiving TPN 12 (9.3) 8 (9.9) 4 (8.3) 1.000
Receiving medical formula at home after discharge 32 (24.8) 14 (17.3) 18 (37.5) 0.010
Receiving tube feeding at home after discharge 12 (9.3) 5 (6.2) 7 (14.6) 0.127
Surgical admission 51 (39.5) 35 (43.2) 16 (33.3) 0.267
PRISM III [17] 3.0 (0.0–6.5) 3.0 (0.5–6.0) 3.0 (0.0–7.8) 0.860
Inotropes 82 (63.6) 50 (61.7) 32 (66.7) 0.573
VIS [18] 14.0 (5.8–34.8) 13.0 (5.8–34.8) 14.0 (5.2–21.8) 0.279
ECMO support 15 (11.6) 7 (8.6) 8 (16.7) 0.169
Mechanically ventilated 110 (85.3) 70 (86.4) 40 (83.3) 0.633
Median ventilator day 6.0 (2.0–14.0) 4.5 (2.0–10.2) 9.5 (4.0–18.8) 0.805
Ventilator >7 day 48 (37.2) 25 (30.9) 23 (47.9) 0.027
Median PICU stay (day) 9.0 (5.0–17.0) 9.0 (4.0–15.0) 12.5 (5.2–21.8) 0.184
PICU >7 day 81 (62.8) 50 (61.7) 31 (64.6) 0.746
Sedation 103 (79.8) 67 (82.7) 36 (75.0) 0.291
Sedation >7 day 41 (31.8) 23 (28.4) 18 (37.5) 0.121
NMB use 29 (22.5) 17 (21.0) 12 (25.0) 0.598
NMB >7 day 14 (10.9) 7 (8.6) 7 (14.6) 0.362
PCPC at 1 mo 0.016
 Normal 48 (37.2) 33 (40.7) 15 (31.3)
 Mild disability 38 (29.5) 29 (35.8) 9 (18.7)
 Moderate disability 23 (17.8) 11 (13.6) 12 (25.0)
 Severe disability 20 (15.5) 8 (9.9) 12 (25.0)
PCPC at 1 yr 0.016
 Normal 72 (55.8) 49 (60.5) 23 (47.9)
 Mild disability 28 (21.7) 21 (25.9) 7 (14.6)
 Moderate disability 16 (12.4) 6 (7.4) 10 (20.8)
 Severe disability 13 (10.1) 5 (6.2) 8 (16.7)

Values are presented as median (interquartile range) or number (%).

TPN: total parenteral nutrition; PRISM III: Pediatric Risk of Mortality III score; VIS: vasoactive inotropic score; ECMO: extracorporeal membrane oxygenation; PICU: pediatric intensive care unit; NMB: neuromuscular blocker; PCPC: Pediatric Cerebral Performance Category.

Table 2.
Univariate and multivariate analyses for any malnutrition at any time point after discharge
Factor Crude OR (95% CI) P-value Adjusted OR (95% CI)a) P-value
Age <1 yr 0.97 (0.46–2.02) 0.930 - -
Male sex 0.86 (0.41–1.83) 0.699 - -
Underlying disease 1.67 (0.77–3.71) 0.243 - -
Cardiac diagnosis 0.63 (0.31–1.30) 0.211 - -
Baseline malnutrition 12.19 (5.20–28.57) <0.001 16.52 (5.63–48.41) <0.001
Delayed development 2.78 (0.98–7.89) 0.061 - -
Full enteral feeding later than 7 day 1.35 (0.58–3.18) 0.485 - -
Receiving TPN 0.83 (0.24–2.92) 1.000 - -
Medical formula at home 2.87 (1.26–6.52) 0.010 2.12 (0.63–7.08) 0.223
Tube feeding at home 2.60 (0.77–8.69) 0.127 - -
Surgical admission 0.66 (0.31–1.38) 0.267 - -
Inotropes 2.11 (0.71–6.26) 0.573 - -
ECMO support 0.88 (0.24–3.23) 0.169 - -
Mechanically ventilated 0.77 (0.29–2.11) 0.633 - -
Ventilator >7 day 2.43 (1.10–5.39) 0.027 1.84 (0.61–5.55) 0.276
Sedation 0.62 (0.26–1.50) 0.291 - -
Sedation >7 day 1.91 (0.84–4.37) 0.121 - -
NMB 1.25 (0.54–2.92) 0.598 - -
NMB >7 day 2.00 (0.45–8.96) 0.362 - -
PICU >7 day 1.13 (0.54–2.37) 0.746 - -
At least moderate dysfunction 4.06 (1.85–8.92) <0.001 3.46 (1.05–11.34) 0.041

OR: odds ratio; TPN: total parenteral nutrition; ECMO: extracorporeal membrane oxygenation; NMB: neuromuscular blocker; PICU: pediatric intensive care unit.

a)Adjusted for baseline malnutrition, medical formula at home, ventilator >7 days, and at least moderate dysfunction.

Table 3.
Risk factors for the development of malnutrition at 1 month and 1 year after discharge
Factor Normal nutrition at 1 mo (n=83) Malnutrition at 1 mo (n=46) P-value Normal nutrition at 1 yr (n=100) Malnutrition at 1 yr (n=29) P-value
Age (yr) 1.6 (0.4–4.1) 2.6 (0.4–6.9) 0.609 1.6 (0.4–4.3) 3.8 (0.4–7.9) 0.510
Age <1 yr 33 (39.8) 16 (34.8) 0.577 39 (39.0) 10 (34.5) 0.659
Male sex 56 (67.5) 30 (65.2) 0.795 66 (66.0) 20 (69.0) 0.765
Weight at 1 mo (kg) 11.0 (6.9–16.7) 13.0 (5.6–26.1) 0.325 13.0 (10.5–19.0) 17.6 (9.2–34.5) 0.373
Height at 1 mo (cm) 84.0 (68.0–102.0) 92.5 (64.8–116.0) 0.325 92.2 (81.0–108.9) 108.5 (79.5–124.0) 0.324
Underlying disease 0.760 0.152
 None 29 (34.9) 12 (26.1) 34 (34.0) 7 (24.2)
 Cardiovascular 38 (45.9) 26 (56.5) 52 (52.0) 12 (41.5)
 Genetic 3 (3.6) 2 (4.3) 3 (3.0) 2 (6.9)
 Pulmonology 3 (3.6) 2 (4.3) 3 (3.0) -
 Neurology 3 (3.6) 1 (2.2) 2 (2.0) 3 (10.3)
 Allergy 3 (3.6) - 2 (2.0) 2 (6.9)
 Gastrointestinal 1 (1.2) 1 (2.2) 1 (1.0) 1 (3.4)
 Developmental disorder 1 (1.2) 1 (2.2) 1 (1.0) 1 (3.4)
 Hematology and oncology 1 (1.2) - 1 (1.0) -
 Rheumatology - 1 (2.2) - 1 (3.4)
 Nephrology 1 (1.2) - 1 (1.0) -
Admission diagnosis 0.303 0.147
 Cardiovascular 48 (57.8) 23 (50.0) 59 (59.0) 12 (41.5)
 Pulmonology 13 (15.8) 12 (26.1) 16 (16.0) 9 (31.2)
 Neurology 9 (10.8) 4 (8.7) 11 (11.0) 2 (6.9)
 Gastrointestinal 5 (6.0) 1 (2.2) 5 (5.0) 1 (3.4)
 Hematology and oncology 2 (2.4) 2 (4.3) 3 (3.0) 1 (3.4)
 Nephrology 3 (3.6) - 3 (3.0) -
 Dermatology 1 (1.2) 1 (2.2) 1 (1.0) 1 (3.4)
 Septic shock - 2 (4.3) 1 (1.0) 1 (3.4)
 Trauma - 1 (2.2) - 1 (3.4)
 Genetic 1 (1.2) - 1 (1.0) -
 Allergy 1 (1.2) - - 1 (3.4)
Baseline malnutrition 15 (18.1) 37 (80.4) <0.001 30 (30.0) 22 (75.9) <0.001
Baseline global developmental delay 8 (9.6) 9 (19.6) 0.110 9 (9.0) 8 (27.6) 0.024
Time for enteral feeding initiation (day) 2.0 (1.0–3.0) 2.5 (1.0–3.0) 0.138 2.0 (1.0–3.0) 3.0 (2.0–3.0) 0.101
Time to full enteral feeding (day) 4.0 (3.0–7.0) 5.0 (3.8–7.3) 0.448 4.0 (3.0–7.0) 5.0 (4.0–9.5) 0.280
Full enteral feeding after 7 day 17 (20.5) 11 (23.9) 0.651 19 (19.0) 9 (31.0) 0.166
Receiving TPN 8 (9.6) 4 (8.7) 1.000 9 (9.0) 3 (10.3) 0.731
Receiving medical formula at home after discharge 15 (18.1) 17 (37.0) 0.017 23 (23.0) 9 (31.0) 0.378
Receiving tube feeding at home after discharge 5 (6.0) 7 (15.2) 0.114 8 (8.0) 4 (13.8) 0.466
Surgical admission 34 (41.0) 17 (37.0) 0.656 43 (43.0) 8 (27.6) 0.135
Median PRISM III [17] 4.0 (2.0–6.0) 3.0 (0.0–7.0) 0.554 3.0 (0.2–6.0) 3.0 (0.0–7.0) 0.853
Inotropes 51 (61.4) 31 (67.4) 0.502 66 (66.0) 16 (55.2) 0.286
VIS [18] 14.0 (8.0–34.0) 14.0 (5.0–40.0) 0.823 13.0 (5.0–34.8) 14.0 (10.0–37.2) 0.875
ECMO support 8 (9.6) 7 (15.2) 0.344 9 (9.0) 6 (20.7) 0.102
Mechanically ventilated 72 (86.7) 38 (82.6) 0.525 85 (85.0) 25 (86.2) 1.000
Ventilator day 5.0 (2.0–10.8) 9.5 (4.0–19.0) 0.018 5.0 (1.5–11.0) 11.0 (5.0–18.5) 0.025
Ventilator >7 day 26 (31.3) 22 (47.8) 0.028 32 (32.0) 16 (55.2) 0.020
PICU stay (day) 9.0 (4.0–15.0) 12.5 (5.8–22.0) 0.176 8.0 (4.0–15.8) 13.0 (8.0–22.0) 0.010
PICU >7 day 52 (62.7) 29 (63.0) 0.965 59 (59.0) 22 (75.9) 0.098
Sedation 69 (83.1) 34 (73.9) 0.211 81 (81.0) 22 (75.9) 0.544
Sedation >7 day 24 (28.9) 17 (37.0) 0.138 28 (28.0) 13 (44.8) 0.037
NMB use 17 (20.5) 12 (26.1) 0.465 19 (19.0) 10 (34.5) 0.079
NMB >7 day 7 (8.4) 7 (15.2) 0.362 8 (8.0) 6 (20.7) 0.450
PCPC 0.057 0.034
 Normal 33 (39.8) 15 (32.6) 58 (58.0) 14 (48.3)
 Mild disability 29 (34.9) 9 (19.6) 25 (25.0) 3 (10.3)
 Moderate disability 12 (14.5) 11 (23.9) 9 (9.0) 7 (24.2)
 Severe disability 9 (10.8) 11 (23.9) 8 (8.0) 5 (17.2)

Values are presented as median (interquartile range) or number (%).

TPN: total parenteral nutrition; PRISM III: Pediatric Risk of Mortality III score; VIS: vasoactive inotropic score; ECMO: extracorporeal membrane oxygenation; PICU: pediatric intensive care unit; NMB: neuromuscular blocker; PCPC: Pediatric Cerebral Performance Category.

Table 4.
Univariate and multivariate analyses for any malnutrition at 1 month and 1 year after discharge
Factor Crude OR at 1 mo (95% CI) Adjusted OR at 1 mo (95% CI)a) Crude OR at 1 yr (95% CI) Adjusted OR at 1 yr (95% CI)b)
Age <1 yr 0.81 (0.38–1.71) - 0.82 (0.35–1.95) -
Male sex 0.90 (0.42–1.93) - 1.14 (0.47–2.78) -
Underlying disease 1.52 (0.68–3.38) - 1.62 (0.63–4.17) -
Cardiac diagnosis 0.73 (0.35–1.50) - 0.49 (0.21–1.14) -
Baseline malnutrition 18.64 (7.44–46.68) 31.42 (9.35–105.62) 7.33 (2.83–19.00) 5.69 (1.82–17.72)
Delayed development 2.28 (0.81–6.39) - 3.85 (1.33–11.16) 1.32 (0.30–5.78)
Full enteral feeding later than 7 day 1.22 (0.52–2.89) - 1.92 (0.75–4.87) -
Receiving TPN 0.89 (0.25–3.14) - 1.17 (0.29–4.62) -
Medical formula at home 2.66 (1.17–6.03) 2.30 (0.61–8.62) 1.51 (0.60–3.76) -
Tube feeding at home 2.80 (0.83–9.39) - 1.84 (0.51–6.61) -
Surgical admission 0.84 (0.40–1.77) - 0.50 (0.20–1.25) -
Inotropes 1.30 (0.61–2.77) - 0.63 (0.27–1.47) -
ECMO support 1.68 (0.57–4.98) - 2.64 (0.85–8.16) -
Mechanically ventilated 0.73 (0.27–1.96) - 1.10 (0.34–3.62) -
Ventilator >7 day 2.43 (1.09–5.43) 2.43 (0.72–8.24) 2.94 (1.16–7.44) 0.40 (0.04–4.07)
Sedation 0.57 (0.24–1.38) - 0.74 (0.27–1.98) -
Sedation >7 day 1.87 (0.81–4.32) - 2.73 (1.04–7.18) 4.89 (0.54–44.44)
NMB 1.37 (0.59–3.20) - 2.24 (0.90–5.60) -
NMB >7 day 2.00 (0.45–8.96) - 2.06 (0.43–9.80) -
PICU >7 day 1.02 (0.48–2.14) - 2.18 (0.85–5.59) -
At least moderate dysfunction 2.71 (1.26–5.79) 2.22 (0.61–8.05) 3.45 (1.39–8.52) 5.15 (1.21–21.95)

OR: odds ratio; TPN: total parenteral nutrition; ECMO: extracorporeal membrane oxygenation; NMB: neuromuscular blocker; PICU: pediatric intensive care unit.

a)Adjusted for baseline malnutrition, medical formula at home, ventilator >7 day, and at least moderate dysfunction;

b)Adjusted for baseline malnutrition, medical formula at home, ventilator >7 day, sedation >7 day, and at least moderate dysfunction.

  • 1. Bagri NK, Jose B, Shah SK, Bhutia TD, Kabra SK, Lodha R, et al. Impact of malnutrition on the outcome of critically ill children. Indian J Pediatr 2015;82:601-5.ArticlePubMedPDF
  • 2. Prince NJ, Brown KL, Mebrahtu TF, Parslow RC, Peters MJ. Weight-for-age distribution and case-mix adjusted outcomes of 14,307 paediatric intensive care admissions. Intensive Care Med 2014;40:1132-9.ArticlePubMedPMCPDF
  • 3. Moreno YF, Ventura JC, Oliveira LD, Silveira TT, Hauschild DB. Undernutrition in critically ill children. Pediatr Med 2020;3:22.Article
  • 4. Briassoulis G, Venkataraman S, Thompson A. Nutritional-metabolic factors affecting nitrogen balance and substrate utilization in the critically ill. J Pediatr Intensive Care 2012;1:77-86.ArticlePubMedPMC
  • 5. Botrán M, López-Herce J, Mencía S, Urbano J, Solana MJ, García A, et al. Relationship between energy expenditure, nutritional status and clinical severity before starting enteral nutrition in critically ill children. Br J Nutr 2011;105:731-7.ArticlePubMed
  • 6. Valla FV, Berthiller J, Gaillard-Le Roux B, Ford-Chessel C, Ginhoux T, Rooze S, et al. Faltering growth in the critically ill child: prevalence, risk factors, and impaired outcome. Eur J Pediatr 2018;177:345-53.ArticlePubMedPDF
  • 7. Hendrikse WH, Reilly JJ, Weaver LT. Malnutrition in a children's hospital. Clin Nutr 1997;16:13-8.Article
  • 8. Ventura JC, Hauschild DB, Barbosa E, Bresolin NL, Kawai K, Mehta NM, et al. Undernutrition at PICU admission is predictor of 60-day mortality and PICU length of stay in critically ill children. J Acad Nutr Diet 2020;120:219-29.ArticlePubMed
  • 9. van Gassel RJ, Baggerman MR, van de Poll MC. Metabolic aspects of muscle wasting during critical illness. Curr Opin Clin Nutr Metab Care 2020;23:96-101.ArticlePubMedPMC
  • 10. Hulst J, Joosten K, Zimmermann L, Hop W, van Buuren S, Büller H, et al. Malnutrition in critically ill children: from admission to 6 months after discharge. Clin Nutr 2004;23:223-32.ArticlePubMed
  • 11. Valla FV, Baudin F, Gaillard Le Roux B, Ford-Chessel C, Gervet E, Giraud C, et al. Nutritional status deterioration occurs frequently during children's ICU stay. Pediatr Crit Care Med 2019;20:714-21.ArticlePubMed
  • 12. World Health Organization (WHO). Guideline: assessing and managing children at primary health-care facilities to prevent overweight and obesity in the context of the double burden of malnutrition: updates for the integrated management of childhood illness (IMCI). Table 1, World Health Organization (WHO) classification of nutritional status of infants and children [Internet]. WHO 2017 [cited 2026 Jun 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK487900/table/fm.s1.t1/
  • 13. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660-7.ArticlePubMedPMC
  • 14. Mehta NM, Corkins MR, Lyman B, Malone A, Goday PS, Carney LN, et al. Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. JPEN J Parenter Enteral Nutr 2013;37:460-81.ArticlePubMed
  • 15. Volaki EM, Sdougka MM, Mantzafleri PE, Tsonidis CH, Kontopoulos E, Tsikoulas I. Functional outcome following pediatric intensive care: Pediatric Cerebral Performance Category (PCPC) and Pediatric Overall Performance Category (POPC) during a prospective two years follow up period. Greek e J Perioper Med 2015;13:2-15.
  • 16. Fiser DH. Assessing the outcome of pediatric intensive care. J Pediatr 1992;121:68-74.ArticlePubMed
  • 17. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated pediatric risk of mortality score. Crit Care Med 1996;24:743-52.ArticlePubMed
  • 18. Belletti A, Lerose CC, Zangrillo A, Landoni G. Vasoactive-Inotropic score: evolution, clinical utility, and pitfalls. J Cardiothorac Vasc Anesth 2021;35:3067-77.ArticlePubMed
  • 19. Rousseau AF, Lucania S, Fadeur M, Verbrugge AM, Cavalier E, Colson C, et al. Adequacy of nutritional intakes during the year after critical illness: an observational study in a post-ICU follow-up clinic. Nutrients 2022;14:3797.ArticlePubMedPMC
  • 20. Fukushima R, Compher CW, Correia MITD, Gonzalez MC, McKeever L, Nakamura K, et al. Recognizing malnutrition in adults with critical illness: guidance statements from the Global Leadership Initiative on Malnutrition. Clin Nutr 2025;49:202-8.ArticlePubMed
  • 21. Nakanishi N, Liu K, Hatakeyama J, Kawauchi A, Yoshida M, Sumita H, et al. Post-intensive care syndrome follow-up system after hospital discharge: a narrative review. J Intensive Care 2024;12:2.ArticlePubMedPMCPDF
  • 22. Salisbury LG, Merriweather JL, Walsh TS. Rehabilitation after critical illness: could a ward-based generic rehabilitation assistant promote recovery? Nurs Crit Care 2010;15:57-65.ArticlePubMed
  • 23. Merriweather JL, Salisbury LG, Walsh TS, Smith P. Nutritional care after critical illness: a qualitative study of patients' experiences. J Hum Nutr Diet 2016;29:127-36.ArticlePubMedPDF
  • 24. Zuercher P, Moret CS, Dziewas R, Schefold JC. Dysphagia in the intensive care unit: epidemiology, mechanisms, and clinical management. Crit Care 2019;23:103.ArticlePubMedPMCPDF
  • 25. Bedock D, Couffignal J, Bel Lassen P, Soares L, Mathian A, Fadlallah JP, et al. Evolution of nutritional status after early nutritional management in COVID-19 hospitalized patients. Nutrients 2021;13:2276.ArticlePubMedPMC
  • 26. Ong C, Lee JH, Senna S, Chia AZ, Wong JJ, Fortier MV, et al. Body composition and acquired functional impairment in survivors of pediatric critical illness. Crit Care Med 2019;47:e445-53.ArticlePubMed
  • 27. Ward SL, VanBuren JM, Richards R, Holubkov R, Alvey JS, Jensen AR, et al. Evaluating the association between obesity and discharge functional status after pediatric injury. J Pediatr Surg 2022;57:598-605.ArticlePubMedPMC
  • 28. Zhou D, Wang C, Lin Q, Li T. The obesity paradox for survivors of critically ill patients. Crit Care 2022;26:198.ArticlePubMedPMCPDF
  • 29. Xu D, Lu Y, Wang Y, Li F. The obesity paradox and 90 day mortality in chronic critically ill patients: a cohort study using a large clinical database. Eur J Med Res 2024;29:392.ArticlePubMedPMCPDF
  • 30. Puthucheary ZA, Astin R, Mcphail MJ, Saeed S, Pasha Y, Bear DE, et al. Metabolic phenotype of skeletal muscle in early critical illness. Thorax 2018;73:926-35.ArticlePubMedPMC
  • 31. Pellegrinelli V, Rouault C, Rodriguez-Cuenca S, Albert V, Edom-Vovard F, Vidal-Puig A, et al. Human adipocytes induce inflammation and atrophy in muscle cells during obesity. Diabetes 2015;64:3121-34.ArticlePubMed
  • 32. Goossens C, Marques MB, Derde S, Vander Perre S, Dufour T, Thiessen SE, et al. Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness. J Cachexia Sarcopenia Muscle 2017;8:89-101.ArticlePubMedPMCPDF

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Nutrition as a neglected domain of post-intensive care syndrome in children
      Insu Choi, Woo Kyung Kim, Hwa Jin Cho
      Acute and Critical Care.2026; 41(3): 708.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Pediatric post-intensive care malnutrition—risk factors and their association with long-term functional outcomes 1 year after discharge: a retrospective cohort study in Thailand
      Acute Crit Care. 2026;41(3):641-653.   Published online August 31, 2026
      Close
    • XML DownloadXML Download
    Figure
    • 0
    Pediatric post-intensive care malnutrition—risk factors and their association with long-term functional outcomes 1 year after discharge: a retrospective cohort study in Thailand
    Image
    Figure 1. Population flowchart. PICU: pediatric intensive care unit. a)Lack either weight or height at any time point.
    Pediatric post-intensive care malnutrition—risk factors and their association with long-term functional outcomes 1 year after discharge: a retrospective cohort study in Thailand
    Factor All patients (n=129) Normal nutrition (n=81) Malnutrition (n=48) P-value
    Age (yr) 2.0 (0–5) 1.6 (0–4) 2.1 (0–7) 0.368
    Age <1 yr 49 (38.0) 31 (38.3) 18 (37.5) 0.930
    Male sex 86 (66.7) 55 (67.9) 31 (64.6) 0.699
    Weight on admission (kg) 11.0 (5.4–18.9) 10.7 (6.2–17.3) 11.7 (4.7–24.4) 0.450
    Height on admission (cm) 85.0 (63.5–108.5) 84.5 (65.0–101.0) 90.0 (61.0–115.0) 0.324
    Underlying disease 0.652
     None 41 (31.7) 29 (35.9) 12 (25.0)
     Cardiovascular 64 (49.5) 38 (46.9) 26 (54.1)
     Genetic 5 (3.9) 2 (2.5) 3 (6.2)
     Pulmonology 5 (3.9) 3 (3.7) 2 (4.2)
     Neurology 4 (3.1) 2 (2.5) 2 (4.2)
     Allergy 3 (2.3) 3 (3.7) -
     Gastrointestinal 2 (1.6) 1 (1.2) 1 (2.1)
     Developmental disorder 2 (1.6) 1 (1.2) 1 (2.1)
     Hematology and oncology 1 (0.8) 1 (1.2) -
     Rheumatology 1 (0.8) - 1 (2.1)
     Nephrology 1 (0.8) 1 (1.2) -
    Admission diagnosis 0.145
     Cardiovascular 71 (55.0) 48 (59.3) 23 (47.9)
     Pulmonology 25 (19.3) 13 (16.1) 12 (25.0)
     Neurology 13 (10.1) 9 (11.1) 4 (8.3)
     Gastrointestinal 6 (4.6) 5 (6.2) 1 (2.1)
     Hematology and oncology 4 (3.1) 1 (1.2) 3 (6.2)
     Nephrology 3 (2.3) 3 (3.7) -
     Dermatology 2 (1.6) 1 (1.2) 1 (2.1)
     Septic shock 2 (1.6) - 2 (4.2)
     Trauma 1 (0.8) - 1 (2.1)
     Genetic 1 (0.8) 1 (1.2) -
     Allergy 1 (0.8) - 1 (2.1)
    Baseline malnutrition 52 (40.3) 16 (19.8) 36 (75.0) <0.001
    Baseline global developmental delay 17 (13.2) 7 (8.6) 10 (20.8) 0.061
    Median time for enteral feeding initiation (day) 2.0 (1.0–3.0) 2.0 (1.0–3.0) 2.5 (1.0–3.0) 0.195
    Time to full enteral feeding (day) 5.0 (3.0–7.0) 4.0 (3.0–7.0) 5.0 (4.0–7.8) 0.309
    Full enteral feeding after 7 day 28 (21.7) 16 (19.8) 12 (25.0) 0.485
    Receiving TPN 12 (9.3) 8 (9.9) 4 (8.3) 1.000
    Receiving medical formula at home after discharge 32 (24.8) 14 (17.3) 18 (37.5) 0.010
    Receiving tube feeding at home after discharge 12 (9.3) 5 (6.2) 7 (14.6) 0.127
    Surgical admission 51 (39.5) 35 (43.2) 16 (33.3) 0.267
    PRISM III [17] 3.0 (0.0–6.5) 3.0 (0.5–6.0) 3.0 (0.0–7.8) 0.860
    Inotropes 82 (63.6) 50 (61.7) 32 (66.7) 0.573
    VIS [18] 14.0 (5.8–34.8) 13.0 (5.8–34.8) 14.0 (5.2–21.8) 0.279
    ECMO support 15 (11.6) 7 (8.6) 8 (16.7) 0.169
    Mechanically ventilated 110 (85.3) 70 (86.4) 40 (83.3) 0.633
    Median ventilator day 6.0 (2.0–14.0) 4.5 (2.0–10.2) 9.5 (4.0–18.8) 0.805
    Ventilator >7 day 48 (37.2) 25 (30.9) 23 (47.9) 0.027
    Median PICU stay (day) 9.0 (5.0–17.0) 9.0 (4.0–15.0) 12.5 (5.2–21.8) 0.184
    PICU >7 day 81 (62.8) 50 (61.7) 31 (64.6) 0.746
    Sedation 103 (79.8) 67 (82.7) 36 (75.0) 0.291
    Sedation >7 day 41 (31.8) 23 (28.4) 18 (37.5) 0.121
    NMB use 29 (22.5) 17 (21.0) 12 (25.0) 0.598
    NMB >7 day 14 (10.9) 7 (8.6) 7 (14.6) 0.362
    PCPC at 1 mo 0.016
     Normal 48 (37.2) 33 (40.7) 15 (31.3)
     Mild disability 38 (29.5) 29 (35.8) 9 (18.7)
     Moderate disability 23 (17.8) 11 (13.6) 12 (25.0)
     Severe disability 20 (15.5) 8 (9.9) 12 (25.0)
    PCPC at 1 yr 0.016
     Normal 72 (55.8) 49 (60.5) 23 (47.9)
     Mild disability 28 (21.7) 21 (25.9) 7 (14.6)
     Moderate disability 16 (12.4) 6 (7.4) 10 (20.8)
     Severe disability 13 (10.1) 5 (6.2) 8 (16.7)
    Factor Crude OR (95% CI) P-value Adjusted OR (95% CI)a) P-value
    Age <1 yr 0.97 (0.46–2.02) 0.930 - -
    Male sex 0.86 (0.41–1.83) 0.699 - -
    Underlying disease 1.67 (0.77–3.71) 0.243 - -
    Cardiac diagnosis 0.63 (0.31–1.30) 0.211 - -
    Baseline malnutrition 12.19 (5.20–28.57) <0.001 16.52 (5.63–48.41) <0.001
    Delayed development 2.78 (0.98–7.89) 0.061 - -
    Full enteral feeding later than 7 day 1.35 (0.58–3.18) 0.485 - -
    Receiving TPN 0.83 (0.24–2.92) 1.000 - -
    Medical formula at home 2.87 (1.26–6.52) 0.010 2.12 (0.63–7.08) 0.223
    Tube feeding at home 2.60 (0.77–8.69) 0.127 - -
    Surgical admission 0.66 (0.31–1.38) 0.267 - -
    Inotropes 2.11 (0.71–6.26) 0.573 - -
    ECMO support 0.88 (0.24–3.23) 0.169 - -
    Mechanically ventilated 0.77 (0.29–2.11) 0.633 - -
    Ventilator >7 day 2.43 (1.10–5.39) 0.027 1.84 (0.61–5.55) 0.276
    Sedation 0.62 (0.26–1.50) 0.291 - -
    Sedation >7 day 1.91 (0.84–4.37) 0.121 - -
    NMB 1.25 (0.54–2.92) 0.598 - -
    NMB >7 day 2.00 (0.45–8.96) 0.362 - -
    PICU >7 day 1.13 (0.54–2.37) 0.746 - -
    At least moderate dysfunction 4.06 (1.85–8.92) <0.001 3.46 (1.05–11.34) 0.041
    Factor Normal nutrition at 1 mo (n=83) Malnutrition at 1 mo (n=46) P-value Normal nutrition at 1 yr (n=100) Malnutrition at 1 yr (n=29) P-value
    Age (yr) 1.6 (0.4–4.1) 2.6 (0.4–6.9) 0.609 1.6 (0.4–4.3) 3.8 (0.4–7.9) 0.510
    Age <1 yr 33 (39.8) 16 (34.8) 0.577 39 (39.0) 10 (34.5) 0.659
    Male sex 56 (67.5) 30 (65.2) 0.795 66 (66.0) 20 (69.0) 0.765
    Weight at 1 mo (kg) 11.0 (6.9–16.7) 13.0 (5.6–26.1) 0.325 13.0 (10.5–19.0) 17.6 (9.2–34.5) 0.373
    Height at 1 mo (cm) 84.0 (68.0–102.0) 92.5 (64.8–116.0) 0.325 92.2 (81.0–108.9) 108.5 (79.5–124.0) 0.324
    Underlying disease 0.760 0.152
     None 29 (34.9) 12 (26.1) 34 (34.0) 7 (24.2)
     Cardiovascular 38 (45.9) 26 (56.5) 52 (52.0) 12 (41.5)
     Genetic 3 (3.6) 2 (4.3) 3 (3.0) 2 (6.9)
     Pulmonology 3 (3.6) 2 (4.3) 3 (3.0) -
     Neurology 3 (3.6) 1 (2.2) 2 (2.0) 3 (10.3)
     Allergy 3 (3.6) - 2 (2.0) 2 (6.9)
     Gastrointestinal 1 (1.2) 1 (2.2) 1 (1.0) 1 (3.4)
     Developmental disorder 1 (1.2) 1 (2.2) 1 (1.0) 1 (3.4)
     Hematology and oncology 1 (1.2) - 1 (1.0) -
     Rheumatology - 1 (2.2) - 1 (3.4)
     Nephrology 1 (1.2) - 1 (1.0) -
    Admission diagnosis 0.303 0.147
     Cardiovascular 48 (57.8) 23 (50.0) 59 (59.0) 12 (41.5)
     Pulmonology 13 (15.8) 12 (26.1) 16 (16.0) 9 (31.2)
     Neurology 9 (10.8) 4 (8.7) 11 (11.0) 2 (6.9)
     Gastrointestinal 5 (6.0) 1 (2.2) 5 (5.0) 1 (3.4)
     Hematology and oncology 2 (2.4) 2 (4.3) 3 (3.0) 1 (3.4)
     Nephrology 3 (3.6) - 3 (3.0) -
     Dermatology 1 (1.2) 1 (2.2) 1 (1.0) 1 (3.4)
     Septic shock - 2 (4.3) 1 (1.0) 1 (3.4)
     Trauma - 1 (2.2) - 1 (3.4)
     Genetic 1 (1.2) - 1 (1.0) -
     Allergy 1 (1.2) - - 1 (3.4)
    Baseline malnutrition 15 (18.1) 37 (80.4) <0.001 30 (30.0) 22 (75.9) <0.001
    Baseline global developmental delay 8 (9.6) 9 (19.6) 0.110 9 (9.0) 8 (27.6) 0.024
    Time for enteral feeding initiation (day) 2.0 (1.0–3.0) 2.5 (1.0–3.0) 0.138 2.0 (1.0–3.0) 3.0 (2.0–3.0) 0.101
    Time to full enteral feeding (day) 4.0 (3.0–7.0) 5.0 (3.8–7.3) 0.448 4.0 (3.0–7.0) 5.0 (4.0–9.5) 0.280
    Full enteral feeding after 7 day 17 (20.5) 11 (23.9) 0.651 19 (19.0) 9 (31.0) 0.166
    Receiving TPN 8 (9.6) 4 (8.7) 1.000 9 (9.0) 3 (10.3) 0.731
    Receiving medical formula at home after discharge 15 (18.1) 17 (37.0) 0.017 23 (23.0) 9 (31.0) 0.378
    Receiving tube feeding at home after discharge 5 (6.0) 7 (15.2) 0.114 8 (8.0) 4 (13.8) 0.466
    Surgical admission 34 (41.0) 17 (37.0) 0.656 43 (43.0) 8 (27.6) 0.135
    Median PRISM III [17] 4.0 (2.0–6.0) 3.0 (0.0–7.0) 0.554 3.0 (0.2–6.0) 3.0 (0.0–7.0) 0.853
    Inotropes 51 (61.4) 31 (67.4) 0.502 66 (66.0) 16 (55.2) 0.286
    VIS [18] 14.0 (8.0–34.0) 14.0 (5.0–40.0) 0.823 13.0 (5.0–34.8) 14.0 (10.0–37.2) 0.875
    ECMO support 8 (9.6) 7 (15.2) 0.344 9 (9.0) 6 (20.7) 0.102
    Mechanically ventilated 72 (86.7) 38 (82.6) 0.525 85 (85.0) 25 (86.2) 1.000
    Ventilator day 5.0 (2.0–10.8) 9.5 (4.0–19.0) 0.018 5.0 (1.5–11.0) 11.0 (5.0–18.5) 0.025
    Ventilator >7 day 26 (31.3) 22 (47.8) 0.028 32 (32.0) 16 (55.2) 0.020
    PICU stay (day) 9.0 (4.0–15.0) 12.5 (5.8–22.0) 0.176 8.0 (4.0–15.8) 13.0 (8.0–22.0) 0.010
    PICU >7 day 52 (62.7) 29 (63.0) 0.965 59 (59.0) 22 (75.9) 0.098
    Sedation 69 (83.1) 34 (73.9) 0.211 81 (81.0) 22 (75.9) 0.544
    Sedation >7 day 24 (28.9) 17 (37.0) 0.138 28 (28.0) 13 (44.8) 0.037
    NMB use 17 (20.5) 12 (26.1) 0.465 19 (19.0) 10 (34.5) 0.079
    NMB >7 day 7 (8.4) 7 (15.2) 0.362 8 (8.0) 6 (20.7) 0.450
    PCPC 0.057 0.034
     Normal 33 (39.8) 15 (32.6) 58 (58.0) 14 (48.3)
     Mild disability 29 (34.9) 9 (19.6) 25 (25.0) 3 (10.3)
     Moderate disability 12 (14.5) 11 (23.9) 9 (9.0) 7 (24.2)
     Severe disability 9 (10.8) 11 (23.9) 8 (8.0) 5 (17.2)
    Factor Crude OR at 1 mo (95% CI) Adjusted OR at 1 mo (95% CI)a) Crude OR at 1 yr (95% CI) Adjusted OR at 1 yr (95% CI)b)
    Age <1 yr 0.81 (0.38–1.71) - 0.82 (0.35–1.95) -
    Male sex 0.90 (0.42–1.93) - 1.14 (0.47–2.78) -
    Underlying disease 1.52 (0.68–3.38) - 1.62 (0.63–4.17) -
    Cardiac diagnosis 0.73 (0.35–1.50) - 0.49 (0.21–1.14) -
    Baseline malnutrition 18.64 (7.44–46.68) 31.42 (9.35–105.62) 7.33 (2.83–19.00) 5.69 (1.82–17.72)
    Delayed development 2.28 (0.81–6.39) - 3.85 (1.33–11.16) 1.32 (0.30–5.78)
    Full enteral feeding later than 7 day 1.22 (0.52–2.89) - 1.92 (0.75–4.87) -
    Receiving TPN 0.89 (0.25–3.14) - 1.17 (0.29–4.62) -
    Medical formula at home 2.66 (1.17–6.03) 2.30 (0.61–8.62) 1.51 (0.60–3.76) -
    Tube feeding at home 2.80 (0.83–9.39) - 1.84 (0.51–6.61) -
    Surgical admission 0.84 (0.40–1.77) - 0.50 (0.20–1.25) -
    Inotropes 1.30 (0.61–2.77) - 0.63 (0.27–1.47) -
    ECMO support 1.68 (0.57–4.98) - 2.64 (0.85–8.16) -
    Mechanically ventilated 0.73 (0.27–1.96) - 1.10 (0.34–3.62) -
    Ventilator >7 day 2.43 (1.09–5.43) 2.43 (0.72–8.24) 2.94 (1.16–7.44) 0.40 (0.04–4.07)
    Sedation 0.57 (0.24–1.38) - 0.74 (0.27–1.98) -
    Sedation >7 day 1.87 (0.81–4.32) - 2.73 (1.04–7.18) 4.89 (0.54–44.44)
    NMB 1.37 (0.59–3.20) - 2.24 (0.90–5.60) -
    NMB >7 day 2.00 (0.45–8.96) - 2.06 (0.43–9.80) -
    PICU >7 day 1.02 (0.48–2.14) - 2.18 (0.85–5.59) -
    At least moderate dysfunction 2.71 (1.26–5.79) 2.22 (0.61–8.05) 3.45 (1.39–8.52) 5.15 (1.21–21.95)
    Table 1. Demographic data based on nutritional status after discharge

    Values are presented as median (interquartile range) or number (%).

    TPN: total parenteral nutrition; PRISM III: Pediatric Risk of Mortality III score; VIS: vasoactive inotropic score; ECMO: extracorporeal membrane oxygenation; PICU: pediatric intensive care unit; NMB: neuromuscular blocker; PCPC: Pediatric Cerebral Performance Category.

    Table 2. Univariate and multivariate analyses for any malnutrition at any time point after discharge

    OR: odds ratio; TPN: total parenteral nutrition; ECMO: extracorporeal membrane oxygenation; NMB: neuromuscular blocker; PICU: pediatric intensive care unit.

    Adjusted for baseline malnutrition, medical formula at home, ventilator >7 days, and at least moderate dysfunction.

    Table 3. Risk factors for the development of malnutrition at 1 month and 1 year after discharge

    Values are presented as median (interquartile range) or number (%).

    TPN: total parenteral nutrition; PRISM III: Pediatric Risk of Mortality III score; VIS: vasoactive inotropic score; ECMO: extracorporeal membrane oxygenation; PICU: pediatric intensive care unit; NMB: neuromuscular blocker; PCPC: Pediatric Cerebral Performance Category.

    Table 4. Univariate and multivariate analyses for any malnutrition at 1 month and 1 year after discharge

    OR: odds ratio; TPN: total parenteral nutrition; ECMO: extracorporeal membrane oxygenation; NMB: neuromuscular blocker; PICU: pediatric intensive care unit.

    Adjusted for baseline malnutrition, medical formula at home, ventilator >7 day, and at least moderate dysfunction;

    Adjusted for baseline malnutrition, medical formula at home, ventilator >7 day, sedation >7 day, and at least moderate dysfunction.


    ACC : Acute and Critical Care
    TOP